M&A

Does FTC attempt to block Amgen's Horizon buy spell trouble for Pfizer-Seagen? Not necessarily, analysts say
Does FTC attempt to block Amgen's Horizon buy spell trouble for Pfizer-Seagen? Not necessarily, analysts say
Fierce Pharma
FTC
M&A
Amgen
Horizon Therapeutics
Pfizer
Seagen
antitrust
Flag link:
Heightened US antitrust fears rattle biopharma
Heightened US antitrust fears rattle biopharma
EP Vantage
M&A
antitrust
Amgen
Astellas
Bellus Health
Globus Medical
GSK
Horizon Therapeutics
Merck
NuVasive
Pfizer
Prometheus Biosciences
Seagen
Flag link:
Amgen ‘Remains Committed’ to $27.8B Horizon Acquisition After FTC Challenge
Amgen ‘Remains Committed’ to $27.8B Horizon Acquisition After FTC Challenge
BioSpace
Amgen
Horizon Therapeutics
M&A
FTC
Flag link:
FTC sues to block Amgen’s $27.8B deal for Horizon Therapeutics
FTC sues to block Amgen’s $27.8B deal for Horizon Therapeutics
Medical Marketing and Media
Amgen
Horizon Therapeutics
FTC
M&A
Flag link:
Pfizer, Seagen kick off antitrust review of $43B merger. Will FTC get on board?
Pfizer, Seagen kick off antitrust review of $43B merger. Will FTC get on board?
Fierce Pharma
Pfizer
Seagen
M&A
antitrust
DOJ
FTC
Flag link:
A struggling biotech wraps its main assets into a new drug company
A struggling biotech wraps its main assets into a new drug company
BioPharma Dive
Cyclerion
M&A
Flag link:
Sobi agrees to buy CTI BioPharma for $1.7bn
Sobi agrees to buy CTI BioPharma for $1.7bn
Pharmaceutical Technology
Sobi
CTI BioPharma
M&A
hematology
Flag link:
Biopharma Bets Big on Antibody-Drug Conjugates
Biopharma Bets Big on Antibody-Drug Conjugates
BioSpace
antibody-drug conjugate
Merck
Seagen
M&A
AstraZeneca
BioNTech
Bristol Myers Squibb
Flag link:
Magenta agrees to reverse merger with Dianthus after setbacks
Magenta agrees to reverse merger with Dianthus after setbacks
BioPharma Dive
Magenta Therapeutics
M&A
Dianthus Therapeutics
autoimmune disease
Flag link:
Pfizer kicks newly acquired meds out of Arena as part of midstage cleaning
Pfizer kicks newly acquired meds out of Arena as part of midstage cleaning
Fierce Biotech
Pfizer
Arena Pharmaceuticals
etrasimod
M&A
Flag link:
Sun's Concert hits bum note as FDA imposes partial hold 2 months after $576M buyout
Sun's Concert hits bum note as FDA imposes partial hold 2 months after $576M buyout
Fierce Biotech
Sun Pharma
Concerta Pharmaceuticals
M&A
FDA
Flag link:
AbbVie, Bristol Myers vied for Prometheus before Merck bought it
AbbVie, Bristol Myers vied for Prometheus before Merck bought it
Crain's Chicago Business
Merck
Prometheus Biosciences
M&A
AbbVie
Bristol Myers Squibb
Flag link:
Astellas to acquire eye drug developer Iveric Bio for $5.9B
Astellas to acquire eye drug developer Iveric Bio for $5.9B
BioPharma Dive
Astellas
M&A
Iveric Bio
eye health
Flag link:
'More in the hopper': European Big Pharmas hint M&A could ramp up
'More in the hopper': European Big Pharmas hint M&A could ramp up
Fierce Biotech
Europe
M&A
GSK
Novartis
Roche
Flag link:
Quest Expands in Cancer Testing With $300M Haystack Oncology Acquisition
Quest Expands in Cancer Testing With $300M Haystack Oncology Acquisition
MedCity News
Quest Diagnostics
Haystack Oncology
diagnostics
M&A
liquid biopsy
Medtech
Flag link:
Sanofi, after $8B outlay, sees M&A strategy deliver 2 more duds
Sanofi, after $8B outlay, sees M&A strategy deliver 2 more duds
Fierce Biotech
Sanofi
M&A
earnings
Ablynx
Principia Biopharma
Flag link:
3 Biotechs That Might Get Bought Out in 2023
3 Biotechs That Might Get Bought Out in 2023
Motley Fool
M&A
Madrigal Pharmaceuticals
Amylyx
Aurinia Pharmaceuticals
Flag link:
Big pharma’s biggest spenders revealed: 2022 edition
Big pharma’s biggest spenders revealed: 2022 edition
EP Vantage
M&A
R&D
AbbVie
AstraZeneca
Bristol Myers Squibb
Eli Lilly
GSK
JNJ
Merck
Novartis
Pfizer
Roche
Sanofi
Flag link:
Big Pharmas finally strike with GSK, Merck acquisitions, signaling accelerating pace of M&A
Big Pharmas finally strike with GSK, Merck acquisitions, signaling accelerating pace of M&A
Fierce Pharma
Big Pharma
M&A
Merck
Prometheus Biosciences
GSK
Bellus Health
Flag link:
GSK coughs up $2B for Bellus Health
GSK coughs up $2B for Bellus Health
Medical Marketing and Media
GSK
Bellus Health
M&A
chronic cough
Camlipixant
Flag link:

Pages